Literature DB >> 28149616

Locoregional recurrence after VATS surgery for NSCLC.

Pierre-Emmanuel Falcoz1, Gilbert Massard1.   

Abstract

Entities:  

Year:  2016        PMID： 28149616      PMCID： PMC5227236          DOI： 10.21037/jtd.2016.12.54

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  19 in total

1.  Is local control necessarily an indicator of quality?

Authors:  D A L Morgan; J M Kurtz
Journal:  Eur J Cancer       Date:  2004-03       Impact factor: 9.162

2.  [Practical issues in the surgical treatment of non-small cell lung cancer. Recommendations from the French Society of Thoracic and Cardiovascular Surgery].

Authors:  P Thomas; M Dahan; M Riquet; G Massart; P-E Falcoz; L Brouchet; F Le Pimpec Barthes; C Doddoli; E Martinod; E Fadel; H Porte Pour La Société Française De Chirurgie Thoracique Et Cardio-Vasculaire
Journal:  Rev Mal Respir       Date:  2008-10       Impact factor: 0.622

3.  Patterns of recurrence and incidence of second primary tumors after lobectomy by means of video-assisted thoracoscopic surgery (VATS) versus thoracotomy for lung cancer.

Authors:  Raja M Flores; Ugonna N Ihekweazu; Nabil Rizk; Joseph Dycoco; Manjit S Bains; Robert J Downey; Prasad Adusumilli; David J Finley; James Huang; Valerie W Rusch; Inderpal Sarkaria; Bernard Park
Journal:  J Thorac Cardiovasc Surg       Date:  2010-11-05       Impact factor: 5.209

Review 4.  Locoregional recurrence after pulmonary sublobar resection of non-small cell lung cancer: can it be reduced by considering cancer cells at the surgical margin?

Authors:  Noriyoshi Sawabata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-09-29

5.  Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non-Small Cell Lung Cancer: A Propensity Score Matching Study.

Authors:  Hiroyuki Adachi; Kentaro Sakamaki; Teppei Nishii; Taketsugu Yamamoto; Takuya Nagashima; Yoshihiro Ishikawa; Kohei Ando; Kazuki Yamanaka; Katsuya Watanabe; Yutaka Kumakiri; Masahiro Tsuboi; Takamitsu Maehara; Haruhiko Nakayama; Munetaka Masuda
Journal:  J Thorac Oncol       Date:  2016-08-20       Impact factor: 15.609

6.  Type of lymph node involvement and survival in pathologic N1 stage III non-small cell lung carcinoma.

Authors:  E van Velzen; A B de la Rivière; H J Elbers; J W Lammers; J M van den Bosch
Journal:  Ann Thorac Surg       Date:  1999-04       Impact factor: 4.330

7.  Locoregional control of thoracoscopic lobectomy with selective lymphadenectomy for lung cancer.

Authors:  Junji Ichinose; Tadasu Kohno; Sakashi Fujimori; Mingyon Mun
Journal:  Ann Thorac Surg       Date:  2010-07       Impact factor: 4.330

8.  Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.

Authors:  Terumoto Koike; Teruaki Koike; Katsuo Yoshiya; Masanori Tsuchida; Shin-ichi Toyabe
Journal:  J Thorac Cardiovasc Surg       Date:  2013-08       Impact factor: 5.209

9.  Recurrence of mediastinal node cancer after lobe-specific systematic nodal dissection for non-small-cell lung cancer.

Authors:  Tomohiro Maniwa; Takehiro Okumura; Mitsuhiro Isaka; Kazuo Nakagawa; Yasuhisa Ohde; Haruhiko Kondo
Journal:  Eur J Cardiothorac Surg       Date:  2013-05-03       Impact factor: 4.191

10.  Risk factors for locoregional recurrence in patients with resected N1 non-small cell lung cancer: a retrospective study to identify patterns of failure and implications for adjuvant radiotherapy.

Authors:  Chengcheng Fan; Shugeng Gao; Zhouguang Hui; Jun Liang; Jima Lv; Xiaozhen Wang; Jie He; Luhua Wang
Journal:  Radiat Oncol       Date:  2013-12-09       Impact factor: 3.481
View more
  1 in total

1.  Quality assessment of robot assisted thoracic surgical resection of non-small cell lung cancer: nodal upstaging and mediastinal recurrence.

Authors:  Ghada M Shahin; Besir Topal; Sjaak Pouwels; Thanasie L Markou; Rody Boon; Jos A Stigt
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.